Oncopeptides AB (publ) (LON:0RN4)
London · Delayed Price · Currency is GBP · Price in SEK 2.853
-0.120 (-4.04%)
At close: Feb 4, 2026
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 63.53 million as of February 5, 2026. Its market cap has increased by 189.48% in one year.
Market Cap
63.53M
Enterprise Value
63.60M
Revenue
4.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.85
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 63.53M, a decrease of -57.38%. That is a compound annual growth rate of -9.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 63.53M | -39.96% |
| Dec 30, 2025 | 105.82M | 336.80% |
| Dec 30, 2024 | 24.23M | -57.05% |
| Dec 29, 2023 | 56.41M | -38.17% |
| Dec 30, 2022 | 91.23M | 76.11% |
| Dec 30, 2021 | 51.80M | -94.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Home Reit | 71.94M |
| Watkin Jones | 70.59M |
| Hansard Global | 69.74M |
| Braemar | 69.33M |
| Blackfinch Spring VCT | 68.17M |
| Fevara | 67.56M |
| Oxford Metrics | 66.80M |
| Centaur Media | 65.14M |